ALX

ALX
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $53.424M ▲ | $35.197M ▼ | $5.968M ▼ | 11.171% ▼ | $1.16 ▼ | $29.867M ▲ |
| Q2-2025 | $51.589M ▼ | $36.596M ▲ | $6.12M ▼ | 11.863% ▼ | $1.19 ▼ | $28.42M ▼ |
| Q1-2025 | $54.915M ▼ | $35.754M ▼ | $12.312M ▲ | 22.42% ▲ | $2.4 ▲ | $32.495M ▼ |
| Q4-2024 | $55.91M ▲ | $36.637M ▲ | $12.277M ▲ | 21.959% ▲ | $2.39 ▲ | $35.132M ▲ |
| Q3-2024 | $55.675M | $33.403M | $6.678M | 11.995% | $1.3 | $33.911M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $352.258M ▲ | $1.296B ▼ | $1.168B ▼ | $128.326M ▼ |
| Q2-2025 | $313.036M ▼ | $1.321B ▼ | $1.175B ▲ | $145.447M ▼ |
| Q1-2025 | $319.897M ▼ | $1.333B ▼ | $1.17B ▲ | $163.089M ▼ |
| Q4-2024 | $338.532M ▼ | $1.341B ▼ | $1.164B ▼ | $176.859M ▼ |
| Q3-2024 | $354.817M | $1.365B | $1.174B | $190.689M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.968M ▼ | $-9.267M ▼ | $-4.353M ▲ | $-24.427M ▼ | $-38.047M ▼ | $-9.267M ▼ |
| Q2-2025 | $6.12M ▼ | $43.567M ▲ | $-6.612M ▲ | $-24.295M ▼ | $12.66M ▲ | $43.567M ▲ |
| Q1-2025 | $12.312M ▲ | $15.72M ▼ | $-8.021M ▲ | $-23.89M ▲ | $-16.191M ▼ | $15.72M ▼ |
| Q4-2024 | $12.277M ▲ | $30.81M ▲ | $-9.949M ▼ | $-24.201M ▲ | $-3.34M ▲ | $30.81M ▲ |
| Q3-2024 | $6.678M | $-5.031M | $-3.654M | $-118.516M | $-127.201M | $-5.031M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Direct Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Parking | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Alexander’s is a small, highly focused New York City retail and mixed-use REIT whose story is defined by a few marquee properties and a deep partnership with Vornado. The top line has crept higher over time, but reported earnings have been volatile, reflecting the impact of leverage, one-off items, and concentration in a small portfolio. The balance sheet is asset-rich but heavily financed with debt, leaving the company exposed to interest-rate shifts and property value swings, though supported by prime locations and long-term leases. Cash flows from operations are steady and positive, suggesting the core portfolio is functioning well, even if recent cash generation has softened a bit. Strategically, the main opportunities lie in redevelopment and tenant optimization within an already strong footprint, while the main risks center on dependence on a few key assets and tenants, the health of New York’s office and retail markets, and the strategic choices made by Vornado as external manager.
NEWS
November 18, 2025 · 11:00 AM UTC
ALX Oncology to Present at Upcoming Investor Conferences
Read more
November 7, 2025 · 8:15 AM UTC
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Read more
November 3, 2025 · 9:17 AM UTC
Alexander's Announces Third Quarter Financial Results
Read more
October 30, 2025 · 8:30 AM UTC
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
Read more
October 29, 2025 · 1:37 PM UTC
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
Read more
About Alexander's, Inc.
https://www.alx-inc.comAlexander's, Inc. is a real estate investment trust which has seven properties in the greater New York City metropolitan area.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $53.424M ▲ | $35.197M ▼ | $5.968M ▼ | 11.171% ▼ | $1.16 ▼ | $29.867M ▲ |
| Q2-2025 | $51.589M ▼ | $36.596M ▲ | $6.12M ▼ | 11.863% ▼ | $1.19 ▼ | $28.42M ▼ |
| Q1-2025 | $54.915M ▼ | $35.754M ▼ | $12.312M ▲ | 22.42% ▲ | $2.4 ▲ | $32.495M ▼ |
| Q4-2024 | $55.91M ▲ | $36.637M ▲ | $12.277M ▲ | 21.959% ▲ | $2.39 ▲ | $35.132M ▲ |
| Q3-2024 | $55.675M | $33.403M | $6.678M | 11.995% | $1.3 | $33.911M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $352.258M ▲ | $1.296B ▼ | $1.168B ▼ | $128.326M ▼ |
| Q2-2025 | $313.036M ▼ | $1.321B ▼ | $1.175B ▲ | $145.447M ▼ |
| Q1-2025 | $319.897M ▼ | $1.333B ▼ | $1.17B ▲ | $163.089M ▼ |
| Q4-2024 | $338.532M ▼ | $1.341B ▼ | $1.164B ▼ | $176.859M ▼ |
| Q3-2024 | $354.817M | $1.365B | $1.174B | $190.689M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.968M ▼ | $-9.267M ▼ | $-4.353M ▲ | $-24.427M ▼ | $-38.047M ▼ | $-9.267M ▼ |
| Q2-2025 | $6.12M ▼ | $43.567M ▲ | $-6.612M ▲ | $-24.295M ▼ | $12.66M ▲ | $43.567M ▲ |
| Q1-2025 | $12.312M ▲ | $15.72M ▼ | $-8.021M ▲ | $-23.89M ▲ | $-16.191M ▼ | $15.72M ▼ |
| Q4-2024 | $12.277M ▲ | $30.81M ▲ | $-9.949M ▼ | $-24.201M ▲ | $-3.34M ▲ | $30.81M ▲ |
| Q3-2024 | $6.678M | $-5.031M | $-3.654M | $-118.516M | $-127.201M | $-5.031M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Direct Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Parking | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Alexander’s is a small, highly focused New York City retail and mixed-use REIT whose story is defined by a few marquee properties and a deep partnership with Vornado. The top line has crept higher over time, but reported earnings have been volatile, reflecting the impact of leverage, one-off items, and concentration in a small portfolio. The balance sheet is asset-rich but heavily financed with debt, leaving the company exposed to interest-rate shifts and property value swings, though supported by prime locations and long-term leases. Cash flows from operations are steady and positive, suggesting the core portfolio is functioning well, even if recent cash generation has softened a bit. Strategically, the main opportunities lie in redevelopment and tenant optimization within an already strong footprint, while the main risks center on dependence on a few key assets and tenants, the health of New York’s office and retail markets, and the strategic choices made by Vornado as external manager.
NEWS
November 18, 2025 · 11:00 AM UTC
ALX Oncology to Present at Upcoming Investor Conferences
Read more
November 7, 2025 · 8:15 AM UTC
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Read more
November 3, 2025 · 9:17 AM UTC
Alexander's Announces Third Quarter Financial Results
Read more
October 30, 2025 · 8:30 AM UTC
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
Read more
October 29, 2025 · 1:37 PM UTC
Alexander's Declares Quarterly $4.50 Dividend on Common Shares
Read more

CEO
Steven Roth
Compensation Summary
(Year 2024)

CEO
Steven Roth
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : B
Price Target
Institutional Ownership

VANGUARD GROUP INC
306.839K Shares
$65.028M

GOLDMAN SACHS GROUP INC
294.229K Shares
$62.356M

EMS CAPITAL LP
250.5K Shares
$53.088M

BLACKROCK, INC.
213.861K Shares
$45.324M

BLACKROCK INC.
178.333K Shares
$37.794M

SOUTHEASTERN ASSET MANAGEMENT INC/TN/
122.712K Shares
$26.006M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
96.249K Shares
$20.398M

MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.
69.46K Shares
$14.721M

BLACKROCK FUND ADVISORS
65.577K Shares
$13.898M

GEODE CAPITAL MANAGEMENT, LLC
57.168K Shares
$12.116M

STATE STREET CORP
54.658K Shares
$11.584M

RENAISSANCE TECHNOLOGIES LLC
48.326K Shares
$10.242M

DIMENSIONAL FUND ADVISORS LP
33.201K Shares
$7.036M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
31.151K Shares
$6.602M

DENALI ADVISORS LLC
29.9K Shares
$6.337M

VOSS CAPITAL, LLC
25.29K Shares
$5.36M

MILLENNIUM MANAGEMENT LLC
23.935K Shares
$5.073M

MORGAN STANLEY
23.914K Shares
$5.068M

UBS GROUP AG
23.405K Shares
$4.96M

BULLDOG INVESTORS, LLP
22.5K Shares
$4.768M
Summary
Only Showing The Top 20

